Company: Merck & Co., Inc.
Ticker: MRK
Form: 10-K
Filed: 2026-02-24
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was Merck & Co., Inc.'s total assets in fiscal year 2025?
Question Type: value_lookup

Concept: Assets
Answer (Numeric): 136866.0
Answer (Display): $136,866 million
Unit: USD millions

Evidence:
[{"chunk_id": "218", "equivalent_chunk_ids": ["218"], "section": "Consolidated Balance Sheet", "supports": ["main"], "text": "Merck & Co., Inc. and Subsidiaries\nDecember 31\n($ in millions except per share amounts)\nAssets\nCurrent Assets\nCash and cash equivalents\n14,565\n13,242\nShort-term investments\nAccounts receivable (net of allowance for doubtful accounts of $\nin 2025\nand $\nin 2024)\n11,775\n10,278\nInventories (excludes inventories of $\n5,681\nin 2025 and $\n4,193\nin 2024\nclassified in Other assets - see Note 7)\n6,658\n6,109\nOther current assets\n10,518\n8,706\nTotal current assets\n43,516\n38,782\nInvestments\nProperty, Plant and Equipment (at cost)\nLand\nBuildings\n17,983\n16,360\nMachinery, equipment and office furnishings\n19,760\n18,283\nConstruction in progress\n9,166\n7,984\n47,230\n42,934\nLess: accumulated depreciation\n21,914\n19,155\n25,316\n23,779\nGoodwill\n21,579\n21,668\nOther Intangibles, Net\n26,681\n16,370\nOther Assets\n18,818\n16,044\n136,866\n117,106\nLiabilities and Equity\nCurrent Liabilities\nLoans payable and current portion of long-term debt\n2,589\n2,649\nTrade accounts payable\n4,404\n4,079\nAccrued and other current liabilities\n14,468\n15,694\nIncome taxes payable\n4,726\n3,914\nDividends payable\n2,140\n2,084\nTotal current liabilities\n28,327\n28,420\nLong-Term Debt\n46,750\n34,462\nDeferred Income Taxes\n1,439\n1,387\nOther Noncurrent Liabilities\n7,688\n6,465\nMerck & Co., Inc. Stockholders’ Equity\nCommon stock, $\n0.50\npar value\nAuthorized -\n6,500,000,000\nshares\nIssued -\n3,577,103,522\nshares in 2025 and 2024\n1,788\nOther paid-in capital\n45,029\n44,704\nRetained earnings\n73,075\n63,069\nAccumulated other comprehensive loss\n4,287\n4,945\n115,605\n104,616\nLess treasury stock, at cost:\n1,102,476,756\nshares in 2025 and\n1,049,466,187\nshares in 2024\n62,999\n58,303\nTotal Merck & Co., Inc. stockholders’ equity\n52,606\n46,313\nNoncontrolling Interests\nTotal equity\n52,662\n46,372\n136,866\n117,106\nThe accompanying notes are an integral part of this consolidated financial statement."}]

Derivation: